APA (7th ed.) Citation

Cabrero, M., López-Corral, L., Jarque, I., de la Cruz-Vicente, F., Pérez- López, E., Valcárcel, D., . . . Caballero, D. (2024). Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients. Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation, 59(3), 359. https://doi.org/10.1038/s41409-023-02171-5

Chicago Style (17th ed.) Citation

Cabrero, Mónica, et al. "Ofatumumab as Part of Reduced Intensity Conditioning in High Risk B-cell Lymphoma Patients." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation 59, no. 3 (2024): 359. https://doi.org/10.1038/s41409-023-02171-5.

MLA (9th ed.) Citation

Cabrero, Mónica, et al. "Ofatumumab as Part of Reduced Intensity Conditioning in High Risk B-cell Lymphoma Patients." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation, vol. 59, no. 3, 2024, p. 359, https://doi.org/10.1038/s41409-023-02171-5.